ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013
Medical oncologists' perceptions of financial incentives in cancer care.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 38 citations in OpenAlex.
- Private equity acquisitions and cancer care: nothing to see here? Not so fast.Journal of the National Cancer Institute · 2026Article
- The impact of vertical integration on health care delivery and costs: Evidence from physician-pharmacy integration.Journal of health economics · 2025Article
- Provider billing margin and cancer treatment selection: population based cohort study.BMJ (Clinical research ed.) · 2025Article
- Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.Cancer · 2024Article
- Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice.The oncologist · 2020Article
- Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019Article
- Choosing wisely in oncology: necessity and obstacles.ESMO open · 2018Review
- Diffusion of Bevacizumab Across Oncology Practices: An Observational Study.Medical care · 2018Observational
- Perspectives of Japanese oncologists on the health economics of innovative cancer treatments.International journal of clinical oncology · 2016Article
- Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2015Article
- Improving outpatient oncology practice: several steps into a long journey.Journal of oncology practice · 2014Article
- Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapy.BMC medical informatics and decision making · 2014Article
- Patient and oncologist discussions about cancer care costs.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2014Article
- Rationing healthcare: who's responsible?Oncology (Williston Park, N.Y.) · 2013Article
Corrections and comments
- Commented on by
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
Abstract
purposeThe cost of cancer care continues to increase at an unprecedented rate. Concerns have been raised about financial incentives associated with the chemotherapy concession in oncology practices and their impact on treatment recommendations.
methodsThe objective of this study was to measure the physician-reported effects of prescribing chemotherapy or growth factors or making referrals to other cancer specialists, hospice, or hospital admissions on medical oncologists' income. US medical oncologists involved in the care of a population-based cohort of patients with lung or colorectal cancer from the Cancer Care Outcomes Research and Surveillance (CanCORS) study were surveyed regarding their perceptions of the impact of prescribing practices or referrals on their income.
resultsAlthough most oncologists reported that their incomes would be unaffected, compared with salaried oncologists, physicians in fee-for-service practice, and those paid a salary with productivity incentives were more likely to report that their income would increase from administering chemotherapy (odds ratios [ORs], 7.05 and 7.52, respectively; both P < .001) or administering growth factors (ORs, 5.60 and 6.03, respectively; both P < .001).
conclusionA substantial proportion of oncologists who are not paid a fixed salary report that their incomes increase when they administer chemotherapy and growth factors. Further research is needed to understand the impact of these financial incentives on both the quality and cost of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.